Cambridge Healthtech Institute’s Inaugural
Peptide Targets: Discovery, Expression, and Validation
January 20-21, 2026
New tools—along with the resurgence of and renewed interest in therapeutic peptides—have reignited peptide target discovery.While chemical synthesis struggles with long, complex peptides, recombinant expression in hosts like E. coli and yeast offers a scalable and sustainable solution. Cambridge Healthtech Institute’s Inaugural Peptide Targets: Discovery, Expression, and Validation explores the evolving pipeline from in silico prediction to expression, structural validation, and functional testing. Advances in AI/ML, codon optimization, library design, and display technologies are transforming discovery workflows. Join experts to explore strategies that improve yield, precision, and confidence in peptide target validation.
Coverage will include, but is not limited to:
- AI/ML Prediction
- Expression Systems (E. coli, Yeast, Insect, Mammalian)
- Codon Optimization & Gene Synthesis
- Library Design
- Purification and Refolding Techniques
- Display Technologies
- Peptide Arrays
- Functional Validation Assays
- CRISPR/Cas9 and Genetic Screens
The deadline for priority consideration is June 27, 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: